Literature DB >> 17275742

Recent advances in Oral Oncology.

Crispian Scully1, Jose V Bagan.   

Abstract

This paper reviews the main papers related to oral squamous cell carcinoma published in 2006 in oral oncology - an international interdisciplinary journal which publishes high quality original research, clinical trials and review articles, and all other scientific articles relating to the aetiopathogenesis, epidemiology, prevention, clinical features, diagnosis, treatment and management of patients with neoplasms in the head and neck, and orofacial disease in patients with malignant disease.

Entities:  

Mesh：

Year:  2007        PMID： 17275742     DOI： 10.1016/j.oraloncology.2006.12.007

Source DB:  PubMed          Journal:  Oral Oncol        ISSN： 1368-8375            Impact factor:   5.337


  13 in total

1.  Cytotoxic effect of Erythroxylum daphnites extract is associated with G1 cell cycle arrest and apoptosis in oral squamous cell carcinoma.

Authors:  Silvia T Elias; Carolina C S Macedo; Luiz A Simeoni; Dâmaris Silveira; Pérola O Magalhães; Adriana Lofrano-Porto; Ricardo D Coletta; Francisco A R Neves; Eliete N S Guerra
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

2.  Development of a Multiplexed Assay for Oral Cancer Candidate Biomarkers Using Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry.

Authors:  Yung-Chin Hsiao; Lang-Ming Chi; Kun-Yi Chien; Wei-Fan Chiang; Szu-Fan Chen; Yao-Ning Chuang; Shih-Yu Lin; Chia-Chun Wu; Ya-Ting Chang; Lichieh Julie Chu; Yi-Ting Chen; Shu-Li Chia; Chih-Yen Chien; Kai-Ping Chang; Yu-Sun Chang; Jau-Song Yu
Journal:  Mol Cell Proteomics       Date:  2017-08-18       Impact factor: 5.911

3.  Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.

Authors:  Karl C Bruckman; Frank Schönleben; Wanglong Qiu; Victoria L Woo; Gloria H Su
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-09-01

4.  Comparison between computed tomography and clinical evaluation in tumour/node stage and follow-up of oral cavity and oropharyngeal cancer.

Authors:  P T Figueiredo; A F Leite; A C Freitas; L A Nascimento; M G Cavalcanti; N S Melo; E N Guerra
Journal:  Dentomaxillofac Radiol       Date:  2010-03       Impact factor: 2.419

5.  A study on oncogenic role of leptin and leptin receptor in oral squamous cell.

Authors:  Syed Rizwan Hussain; Hena Naqvi; Shalini Gupta; Abbas Ali Mahdi; Pratibha Kumari; Mohammad Waseem; Mohammad Kaleem Ahmad
Journal:  Tumour Biol       Date:  2015-03-26

6.  Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS.

Authors:  Lang-Ming Chi; Chien-Wei Lee; Kai-Ping Chang; Sheng-Po Hao; Hang-Mao Lee; Ying Liang; Chuen Hsueh; Chia-Jung Yu; I-Neng Lee; Yin-Ju Chang; Shih-Ying Lee; Yuan-Ming Yeh; Yu-Sun Chang; Kun-Yi Chien; Jau-Song Yu
Journal:  Mol Cell Proteomics       Date:  2009-03-18       Impact factor: 5.911

7.  Association of leptin -2548G/A and leptin receptor Q223R polymorphisms with increased risk for oral cancer.

Authors:  Christos Yapijakis; Michael Kechagiadakis; Emeka Nkenke; Zoe Serefoglou; Dimitrios Avgoustidis; Antonis Vylliotis; Despina Perrea; Friedrich W Neukam; Efstratios Patsouris; Eleftherios Vairaktaris
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-15       Impact factor: 4.553

8.  Licochalcone A as a potent antitumor agent suppresses growth of human oral cancer SCC-25 cells in vitro via caspase-3 dependent pathways.

Authors:  Guang Zeng; Huan Shen; Yongjin Yang; Xingwei Cai; Wenxing Xun
Journal:  Tumour Biol       Date:  2014-04-02

9.  Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma.

Authors:  Kai-Ping Chang; Shih-Jie Lin; Shiau-Chin Liu; Jui-Shan Yi; Kun-Yi Chien; Lang-Ming Chi; Huang-Kai Kao; Ying Liang; Yu-Tsun Lin; Yu-Sun Chang; Jau-Song Yu
Journal:  Sci Rep       Date:  2015-07-03       Impact factor: 4.379

10.  MERTK as a novel therapeutic target in head and neck cancer.

Authors:  Anne von Mässenhausen; Christine Sanders; Britta Thewes; Mario Deng; Angela Queisser; Wenzel Vogel; Glen Kristiansen; Stefan Duensing; Andreas Schröck; Friedrich Bootz; Peter Brossart; Jutta Kirfel; Lynn Heasley; Johannes Brägelmann; Sven Perner
Journal:  Oncotarget       Date:  2016-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.